CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 7.51
-0.07 (-0.92%)
Jul 25, 2025, 4:08 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 10.95 billion as of July 25, 2025. Its market cap has increased by 652.81% in one year.
Market Cap
10.95B
Enterprise Value
10.56B
Revenue
433.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.51
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 10.95B, a decrease of -13.51%. That is a compound annual growth rate of -2.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.12B |
| Hansoh Pharmaceutical Group Company | 203.94B |
| JD Health International | 154.09B |
| Innovent Biologics | 152.40B |
| Akeso | 133.83B |
| WuXi Biologics | 128.18B |
| Sino Biopharmaceutical | 121.08B |
| CSPC Pharmaceutical Group | 98.67B |